| 标题： | 中国慢性肾脏病风险管理公众指南 |
| title： | Chinese Public Guideline for the Management of Chronic Kidney Disease (CKD) Risk |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 该指南适用于各级医院、基层社康中心、疾病预防控制中心等卫生机构。指南的使用人群为全国各民族、地区的一般人群。 |
| Guide users： | The guidelines apply to hospitals at all levels, ground-level community health centers, Centers for Disease Control and prevention and other health institutions. The users of the guidelines are the general population of all ethnic groups and regions in the country. |
| 证据分级方法： | 采用GRADE方法对针对胃癌风险相关证据体质量进行评价。根据GRADE方法，将证据质量分为高、中、低、极低四个等级。在证据分级过程中，考虑五个降级因素——局限性、不精确性、不一致性、不直接性以及发表偏倚，和三个升级因素——效应量大、剂量反应关系以及可能的混杂因素（负偏倚）。完成证据分级后，将通过证据总结表呈现证据。 |
| Evidence grading method： | GRADE method will be used to evaluate certainty (quality) of evidence associated with the risk of gastric cancer. According to GRADE method, the quality of evidence is classified into four grades: high, moderate, low and very low. Five downgrading factors (risk of bias, inconsistency, indirectness, imprecision, and publication bias) and three escalation factors (large effect, plausible confounding, and dose response gradient) are considered in the evidence grading process. After grading the evidence, the evidence will be presented through the "summary of findings" table. |
| 制定单位： | 中国人群健康风险管理协作组-慢性肾脏病专业组 |
| Formulating unit： | Chinese Health Risk Management Collaboration (CHRIMAC) - Chronic Kidney Disease (CKD) Group |
| 注册时间： | 2023-12-22 |
| Registration time： | |
| 注册编号： | PREPARE-2023CN444 |
| Registration number： | |
| 指南制订的目的： | 目前尚缺乏循证指南来指导公众进行慢性肾脏病风险评估，并针对性进行预防干预。因此，本指南的目的是对慢性肾脏病风险评估、高风险人群预防干预措施的相关证据进行系统梳理总结，形成指南，来促进有效的慢性肾脏病防控。 |
| Purpose of the guideline： | There is a lack of evidence-based guidelines to guide the public on chronic kidney disease risk assessment and targeted preventive interventions. Therefore, the purpose of this guideline is to systematically summarize the evidence related to chronic kidney disease risk assessment and preventive interventions for high-risk populations, and to form a guideline to promote effective chronic kidney disease prevention and control. |
